 Tom Shannon
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoplasmic Reticulum | 31 | 2017 | 233 | 5.350 |
Why?
| | Calcium | 37 | 2017 | 519 | 4.750 |
Why?
| | Myocytes, Cardiac | 20 | 2017 | 217 | 4.170 |
Why?
| | Calcium Signaling | 14 | 2017 | 188 | 2.370 |
Why?
| | Myocardial Contraction | 12 | 2016 | 79 | 2.210 |
Why?
| | Myocardium | 18 | 2016 | 183 | 2.110 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 12 | 2016 | 176 | 1.790 |
Why?
| | Heart Failure | 8 | 2010 | 232 | 1.340 |
Why?
| | Isoproterenol | 7 | 2014 | 19 | 1.220 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 6 | 2017 | 43 | 1.070 |
Why?
| | Animals | 42 | 2017 | 5312 | 1.040 |
Why?
| | Heart Ventricles | 12 | 2016 | 218 | 1.000 |
Why?
| | Adrenergic beta-Agonists | 4 | 2013 | 20 | 0.990 |
Why?
| | Arrhythmias, Cardiac | 5 | 2013 | 158 | 0.950 |
Why?
| | Calcium-Transporting ATPases | 10 | 2005 | 26 | 0.900 |
Why?
| | Rabbits | 15 | 2017 | 326 | 0.880 |
Why?
| | Action Potentials | 4 | 2016 | 143 | 0.760 |
Why?
| | Ion Channel Gating | 5 | 2016 | 193 | 0.760 |
Why?
| | Heart | 5 | 2002 | 110 | 0.630 |
Why?
| | Cells, Cultured | 12 | 2016 | 802 | 0.570 |
Why?
| | Diastole | 7 | 2010 | 38 | 0.530 |
Why?
| | Adrenergic Agents | 1 | 2014 | 2 | 0.530 |
Why?
| | Nitric Oxide | 1 | 2014 | 107 | 0.500 |
Why?
| | Receptors, Adrenergic, beta | 2 | 2017 | 14 | 0.490 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 4 | 2010 | 34 | 0.450 |
Why?
| | Calcium-Binding Proteins | 5 | 2011 | 34 | 0.430 |
Why?
| | Calcium Channels | 6 | 2011 | 137 | 0.430 |
Why?
| | Models, Cardiovascular | 4 | 2016 | 23 | 0.420 |
Why?
| | Ventricular Function | 3 | 2007 | 14 | 0.400 |
Why?
| | Patch-Clamp Techniques | 6 | 2016 | 125 | 0.400 |
Why?
| | Calcium Channel Blockers | 1 | 2010 | 40 | 0.400 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2007 | 28 | 0.390 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2009 | 6 | 0.390 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2009 | 13 | 0.390 |
Why?
| | Muscle Relaxants, Central | 1 | 2009 | 5 | 0.380 |
Why?
| | Dantrolene | 1 | 2009 | 2 | 0.380 |
Why?
| | Mice | 9 | 2017 | 1894 | 0.380 |
Why?
| | Kinetics | 9 | 2016 | 278 | 0.350 |
Why?
| | Models, Biological | 5 | 2017 | 428 | 0.340 |
Why?
| | Ventricular Premature Complexes | 1 | 2007 | 3 | 0.340 |
Why?
| | Cytosol | 7 | 2010 | 61 | 0.340 |
Why?
| | Calsequestrin | 1 | 2007 | 39 | 0.330 |
Why?
| | Tachycardia, Ventricular | 1 | 2007 | 35 | 0.330 |
Why?
| | Enzyme Inhibitors | 2 | 2014 | 160 | 0.320 |
Why?
| | Protein Processing, Post-Translational | 1 | 2007 | 45 | 0.320 |
Why?
| | Membrane Potentials | 4 | 2016 | 206 | 0.280 |
Why?
| | Signal Transduction | 3 | 2017 | 588 | 0.270 |
Why?
| | Sarcolemma | 2 | 1994 | 9 | 0.270 |
Why?
| | Microscopy, Confocal | 4 | 2011 | 128 | 0.270 |
Why?
| | Phosphorylation | 5 | 2014 | 199 | 0.260 |
Why?
| | Sodium | 2 | 2016 | 81 | 0.250 |
Why?
| | Mice, Knockout | 3 | 2014 | 399 | 0.240 |
Why?
| | Heart Rate | 2 | 2016 | 161 | 0.230 |
Why?
| | Sulfonamides | 4 | 2011 | 64 | 0.220 |
Why?
| | Tetracaine | 3 | 2007 | 11 | 0.210 |
Why?
| | Peptides | 2 | 2007 | 116 | 0.200 |
Why?
| | Blotting, Western | 3 | 2014 | 225 | 0.180 |
Why?
| | Rats | 9 | 2011 | 966 | 0.180 |
Why?
| | Microsomes | 2 | 2000 | 18 | 0.180 |
Why?
| | Isoquinolines | 2 | 2010 | 16 | 0.180 |
Why?
| | Caffeine | 3 | 2005 | 67 | 0.180 |
Why?
| | Muscle, Skeletal | 3 | 2006 | 385 | 0.170 |
Why?
| | Calcium Channels, L-Type | 2 | 2009 | 62 | 0.170 |
Why?
| | Enzyme Activation | 3 | 2014 | 140 | 0.170 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 10 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2017 | 68 | 0.160 |
Why?
| | Nitric Oxide Synthase | 1 | 2017 | 48 | 0.160 |
Why?
| | Chlorides | 1 | 2016 | 27 | 0.160 |
Why?
| | Magnesium | 1 | 2016 | 52 | 0.160 |
Why?
| | Potassium | 1 | 2016 | 71 | 0.160 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2016 | 37 | 0.150 |
Why?
| | Sodium-Calcium Exchanger | 4 | 2001 | 28 | 0.140 |
Why?
| | Computer Simulation | 3 | 2005 | 249 | 0.140 |
Why?
| | Disease Models, Animal | 2 | 2009 | 832 | 0.140 |
Why?
| | Mice, Inbred C57BL | 2 | 2014 | 548 | 0.140 |
Why?
| | Receptors, Endothelin | 1 | 1994 | 5 | 0.130 |
Why?
| | Phospholipids | 1 | 1994 | 29 | 0.130 |
Why?
| | Thermodynamics | 3 | 2016 | 51 | 0.130 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2014 | 7 | 0.130 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.130 |
Why?
| | Membrane Lipids | 1 | 1994 | 23 | 0.130 |
Why?
| | Benzylamines | 3 | 2011 | 15 | 0.130 |
Why?
| | Ion Transport | 2 | 2004 | 36 | 0.130 |
Why?
| | Carrier Proteins | 1 | 1994 | 129 | 0.130 |
Why?
| | Nuclear Envelope | 1 | 2013 | 6 | 0.120 |
Why?
| | Muscle Cells | 2 | 2010 | 15 | 0.120 |
Why?
| | Cytoplasm | 1 | 2013 | 43 | 0.120 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2011 | 8 | 0.110 |
Why?
| | In Vitro Techniques | 3 | 2011 | 248 | 0.100 |
Why?
| | Humans | 7 | 2016 | 31481 | 0.100 |
Why?
| | Mitochondria, Heart | 1 | 2010 | 21 | 0.100 |
Why?
| | Mice, Inbred mdx | 1 | 2009 | 1 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2010 | 54 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2009 | 79 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2009 | 133 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 6 | 1998 | 494 | 0.090 |
Why?
| | S100 Calcium Binding Protein G | 1 | 2007 | 1 | 0.090 |
Why?
| | Calbindin 2 | 1 | 2007 | 1 | 0.090 |
Why?
| | Protein Binding | 2 | 2000 | 155 | 0.080 |
Why?
| | Colforsin | 1 | 2007 | 13 | 0.080 |
Why?
| | Calmodulin | 1 | 2007 | 12 | 0.080 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2007 | 63 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2007 | 308 | 0.080 |
Why?
| | Disease Progression | 1 | 2009 | 861 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2003 | 87 | 0.070 |
Why?
| | Research Design | 1 | 2007 | 238 | 0.070 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2006 | 43 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 112 | 0.070 |
Why?
| | Image Enhancement | 1 | 2005 | 63 | 0.070 |
Why?
| | Homeostasis | 1 | 2005 | 110 | 0.070 |
Why?
| | Thapsigargin | 2 | 2000 | 8 | 0.070 |
Why?
| | Algorithms | 2 | 2016 | 412 | 0.060 |
Why?
| | Cell Membrane | 1 | 2004 | 132 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 1994 | 254 | 0.060 |
Why?
| | Cattle | 2 | 1994 | 260 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 1994 | 315 | 0.060 |
Why?
| | Intracellular Membranes | 2 | 2000 | 37 | 0.060 |
Why?
| | Models, Theoretical | 2 | 2016 | 112 | 0.060 |
Why?
| | Adenosine Triphosphate | 2 | 2000 | 46 | 0.050 |
Why?
| | Spectrometry, Fluorescence | 2 | 1998 | 15 | 0.050 |
Why?
| | Muscle Contraction | 2 | 2011 | 84 | 0.050 |
Why?
| | Time Factors | 3 | 2000 | 1902 | 0.050 |
Why?
| | Troponin | 1 | 2000 | 11 | 0.050 |
Why?
| | Cell Membrane Permeability | 1 | 1998 | 63 | 0.040 |
Why?
| | Cardiomegaly | 1 | 1998 | 20 | 0.040 |
Why?
| | Calorimetry | 1 | 1997 | 4 | 0.040 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 1997 | 28 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 50 | 0.040 |
Why?
| | Tacrolimus | 1 | 1996 | 15 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 16 | 0.040 |
Why?
| | Cations, Monovalent | 1 | 2016 | 12 | 0.040 |
Why?
| | Intracellular Space | 1 | 2016 | 8 | 0.040 |
Why?
| | Ions | 1 | 2016 | 53 | 0.040 |
Why?
| | Biological Transport | 3 | 2001 | 49 | 0.040 |
Why?
| | Rana pipiens | 2 | 2006 | 53 | 0.040 |
Why?
| | Models, Structural | 1 | 1994 | 6 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 1994 | 7 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 1994 | 12 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 2 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1994 | 30 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1994 | 24 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 1994 | 25 | 0.030 |
Why?
| | Membranes | 1 | 1994 | 10 | 0.030 |
Why?
| | Male | 6 | 2016 | 17583 | 0.030 |
Why?
| | Liposomes | 1 | 1994 | 23 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 1994 | 17 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 1994 | 23 | 0.030 |
Why?
| | Molecular Weight | 1 | 1994 | 58 | 0.030 |
Why?
| | Oligopeptides | 1 | 1994 | 34 | 0.030 |
Why?
| | Peptide Fragments | 1 | 1994 | 122 | 0.030 |
Why?
| | RNA, Messenger | 3 | 1998 | 371 | 0.030 |
Why?
| | Muscle Fatigue | 1 | 2011 | 11 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2011 | 64 | 0.030 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 3 | 0.030 |
Why?
| | Serine | 1 | 2011 | 15 | 0.030 |
Why?
| | Adenosine Triphosphatases | 1 | 2011 | 10 | 0.030 |
Why?
| | Models, Animal | 1 | 2011 | 149 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2009 | 20 | 0.020 |
Why?
| | Ruthenium Red | 2 | 2000 | 8 | 0.020 |
Why?
| | Aging | 1 | 1998 | 1614 | 0.020 |
Why?
| | Down-Regulation | 2 | 1998 | 134 | 0.020 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2005 | 2 | 0.020 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2005 | 4 | 0.020 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2005 | 41 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 40 | 0.020 |
Why?
| | Organelles | 1 | 2005 | 5 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2005 | 50 | 0.020 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 84 | 0.020 |
Why?
| | Echocardiography | 1 | 2005 | 197 | 0.020 |
Why?
| | Allosteric Regulation | 1 | 2001 | 5 | 0.010 |
Why?
| | Ferrets | 1 | 2001 | 15 | 0.010 |
Why?
| | Mutagenesis | 1 | 2001 | 12 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 16 | 0.010 |
Why?
| | Nickel | 1 | 2001 | 30 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2000 | 15 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 283 | 0.010 |
Why?
| | Atrial Natriuretic Factor | 1 | 1998 | 3 | 0.010 |
Why?
| | Ruthenium Compounds | 1 | 1998 | 2 | 0.010 |
Why?
| | Egtazic Acid | 1 | 1998 | 12 | 0.010 |
Why?
| | Chelating Agents | 1 | 1998 | 11 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1998 | 77 | 0.010 |
Why?
| | Ryanodine | 1 | 1998 | 19 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 1998 | 198 | 0.010 |
Why?
| | Indoles | 1 | 1998 | 58 | 0.010 |
Why?
| | Hemodynamics | 1 | 1998 | 103 | 0.010 |
Why?
| | Hydroxyproline | 1 | 1997 | 7 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 1997 | 21 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 1997 | 11 | 0.010 |
Why?
| | Isoenzymes | 1 | 1997 | 63 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1998 | 512 | 0.010 |
Why?
| | Muscle Proteins | 1 | 1996 | 29 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 1996 | 71 | 0.010 |
Why?
| | Gene Expression | 1 | 1997 | 272 | 0.010 |
Why?
| | Histamine | 1 | 1950 | 9 | 0.010 |
Why?
| | Anti-Allergic Agents | 1 | 1950 | 4 | 0.010 |
Why?
| | Post-Dural Puncture Headache | 1 | 1950 | 3 | 0.010 |
Why?
| | Surgery, Plastic | 1 | 1950 | 7 | 0.010 |
Why?
| | Anesthesia | 1 | 1950 | 29 | 0.010 |
Why?
| | Headache | 1 | 1950 | 52 | 0.010 |
Why?
| | Anesthesiology | 1 | 1950 | 28 | 0.010 |
Why?
| | Female | 1 | 2007 | 18253 | 0.010 |
Why?
|
|
Shannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|